Physician profile
Moeen Abedin
NPI 1841403946
$46,617.17
in general payments reported to CMS, 2019-2025
16 companies · $2,834 in 2025
The $2,834 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,027 · 2020: $4,695 · 2021: $3,349 · 2022: $11K · 2023: $4,936 · 2024: $15K · 2025: $2,834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,608 · Travel and Lodging: $7,709 · Food and Beverage: $5,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,607.77 |
| Travel and Lodging | $7,709.17 |
| Food and Beverage | $5,131.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $31,542.55 | 2019-2024 | Ensite, Flexability, Aveir |
| Biotronik INC. | $5,682.73 | 2019-2024 | Acticor 7 Vr-T Dx, Selectra, Biomonitor |
| Medtronic, INC. | $3,552.36 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Biosense Webster, INC. | $1,914.57 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Medical Device Business Services, INC. | $1,383.83 | 2019 | |
| Boston Scientific Corporation | $1,327.66 | 2019-2025 | Watchman Flx, General - Therapies, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $356.96 | 2021-2025 | Lifevest |
| Philips North America LLC | $320.93 | 2019-2025 | Laser Service and Other, (5091) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided |
| Medtronic Vascular, INC. | $134.60 | 2019-2020 | |
| Abiomed | $97.77 | 2025 | |
| Axonics, INC. | $92.51 | 2023 | Axonics |
| Novartis Pharmaceuticals Corporation | $67.31 | 2021 | |
| Atricure, INC. | $63.79 | 2019 | |
| Pfizer INC. | $38.68 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.88 | 2023 | Entyvio |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moeen Abedin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.